ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 307.69 Million USD | 28.23% |
| 2022 | 191.54 Million USD | 59.38% |
| 2021 | 223.45 Million USD | 3.97% |
| 2020 | 194.09 Million USD | -7.93% |
| 2019 | 200.46 Million USD | -22.08% |
| 2018 | 271.89 Million USD | 178.46% |
| 2017 | 205.54 Million USD | -48.44% |
| 2016 | 118.06 Million USD | 17.17% |
| 2015 | 99.94 Million USD | 64.91% |
| 2014 | 63.57 Million USD | -3.9% |
| 2013 | 72.82 Million USD | -10.99% |
| 2012 | 80.27 Million USD | 64.4% |
| 2011 | 84.71 Million USD | -26.57% |
| 2010 | 65 Million USD | 26.76% |
| 2009 | 52.45 Million USD | 28.23% |
| 2008 | 40.9 Million USD | 47.44% |
| 2007 | 27.74 Million USD | -21.95% |
| 2006 | 35.54 Million USD | 2.83% |
| 2005 | 37.29 Million USD | 167.36% |
| 2004 | 5.91 Million USD | -67.96% |
| 2003 | 41.48 Million USD | 19.22% |
| 2002 | 35.28 Million USD | 34.54% |
| 2001 | 27.15 Million USD | 31.49% |
| 2000 | 21.23 Million USD | 20.36% |
| 1999 | 17.3 Million USD | 44.55% |
| 1998 | 12.4 Million USD | 27.91% |
| 1997 | 9.9 Million USD | 28.36% |
| 1996 | 8 Million USD | 3.08% |
| 1995 | 7.2 Million USD | 51.16% |
| 1994 | 4.9 Million USD | 2.38% |
| 1993 | 4.7 Million USD | -10.64% |
| 1992 | 4.9 Million USD | -31.88% |
| 1991 | 4.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 78.11 Million USD | 50.19% |
| 2024 Q1 | 59.29 Million USD | -9.77% |
| 2023 FY | - USD | 28.23% |
| 2023 Q1 | 75.18 Million USD | 914.07% |
| 2023 Q4 | 37.93 Million USD | -44.84% |
| 2023 Q3 | 68.76 Million USD | -8.47% |
| 2023 Q2 | 75.12 Million USD | -0.07% |
| 2022 Q2 | 55.69 Million USD | 21.37% |
| 2022 FY | - USD | 59.38% |
| 2022 Q4 | 7.41 Million USD | -89.22% |
| 2022 Q3 | 68.79 Million USD | 23.52% |
| 2022 Q1 | 45.88 Million USD | 40.13% |
| 2021 Q2 | 63.72 Million USD | 16.14% |
| 2021 Q3 | 40.45 Million USD | -36.52% |
| 2021 FY | - USD | 3.97% |
| 2021 Q4 | 32.74 Million USD | -19.05% |
| 2021 Q1 | 54.86 Million USD | 45.2% |
| 2020 FY | - USD | -7.93% |
| 2020 Q1 | 32.88 Million USD | 2.04% |
| 2020 Q2 | 54.63 Million USD | 66.13% |
| 2020 Q3 | 35.19 Million USD | -35.58% |
| 2020 Q4 | 37.78 Million USD | 7.36% |
| 2019 Q3 | 61.85 Million USD | 144.6% |
| 2019 Q4 | 32.22 Million USD | -47.9% |
| 2019 Q2 | 25.28 Million USD | -49.68% |
| 2019 FY | - USD | -22.08% |
| 2019 Q1 | 50.25 Million USD | 21.41% |
| 2018 Q4 | 41.39 Million USD | -6.42% |
| 2018 Q1 | 68.74 Million USD | 49.38% |
| 2018 Q2 | 72.02 Million USD | 4.76% |
| 2018 Q3 | 44.23 Million USD | -38.58% |
| 2018 FY | - USD | 178.46% |
| 2017 Q1 | -9.82 Million USD | -126.38% |
| 2017 Q4 | 46.02 Million USD | 14.49% |
| 2017 Q3 | 40.19 Million USD | 620.27% |
| 2017 Q2 | 5.58 Million USD | 156.81% |
| 2017 FY | - USD | -48.44% |
| 2016 Q2 | 29.57 Million USD | 2.88% |
| 2016 FY | - USD | 17.17% |
| 2016 Q4 | 37.24 Million USD | 14.87% |
| 2016 Q3 | 32.42 Million USD | 9.64% |
| 2016 Q1 | 28.74 Million USD | -6.85% |
| 2015 FY | - USD | 64.91% |
| 2015 Q4 | 30.86 Million USD | 33.39% |
| 2015 Q1 | 29.72 Million USD | 79.48% |
| 2015 Q3 | 23.13 Million USD | -6.4% |
| 2015 Q2 | 24.71 Million USD | -16.83% |
| 2014 Q3 | 19.06 Million USD | 40.19% |
| 2014 FY | - USD | -3.9% |
| 2014 Q1 | 14.64 Million USD | -21.33% |
| 2014 Q2 | 13.59 Million USD | -7.12% |
| 2014 Q4 | 16.55 Million USD | -13.14% |
| 2013 Q4 | 18.61 Million USD | -8.21% |
| 2013 Q3 | 20.27 Million USD | 28.12% |
| 2013 Q2 | 15.82 Million USD | -5.44% |
| 2013 Q1 | 16.73 Million USD | -28.95% |
| 2013 FY | - USD | -10.99% |
| 2012 FY | - USD | 64.4% |
| 2012 Q2 | 18.15 Million USD | 13.32% |
| 2012 Q3 | 22.1 Million USD | 21.71% |
| 2012 Q4 | 23.55 Million USD | 6.58% |
| 2012 Q1 | 16.02 Million USD | 881.86% |
| 2011 Q2 | 18.1 Million USD | 10.99% |
| 2011 FY | - USD | -26.57% |
| 2011 Q4 | 1.63 Million USD | -90.83% |
| 2011 Q3 | 17.78 Million USD | -1.72% |
| 2011 Q1 | 16.3 Million USD | -22.19% |
| 2010 Q1 | 10.71 Million USD | -29.51% |
| 2010 Q4 | 20.95 Million USD | 10.11% |
| 2010 FY | - USD | 26.76% |
| 2010 Q3 | 19.03 Million USD | 20.53% |
| 2010 Q2 | 15.79 Million USD | 47.4% |
| 2009 Q4 | 15.19 Million USD | 36.17% |
| 2009 FY | - USD | 28.23% |
| 2009 Q1 | 13.96 Million USD | -7.25% |
| 2009 Q2 | 8.36 Million USD | -40.09% |
| 2009 Q3 | 11.16 Million USD | 33.44% |
| 2008 FY | - USD | 47.44% |
| 2008 Q4 | 15.05 Million USD | 13.94% |
| 2008 Q2 | 8.14 Million USD | 81.1% |
| 2008 Q1 | 4.49 Million USD | -48.32% |
| 2008 Q3 | 13.21 Million USD | 62.18% |
| 2007 Q2 | 13.17 Million USD | 998.36% |
| 2007 FY | - USD | -21.95% |
| 2007 Q1 | -1.46 Million USD | -120.8% |
| 2007 Q4 | 8.7 Million USD | 18.72% |
| 2007 Q3 | 7.33 Million USD | -44.37% |
| 2006 Q1 | 9.63 Million USD | -16.77% |
| 2006 Q3 | 7.58 Million USD | -23.79% |
| 2006 Q4 | 7.05 Million USD | -6.99% |
| 2006 FY | - USD | 2.83% |
| 2006 Q2 | 9.95 Million USD | 3.27% |
| 2005 Q2 | 6.84 Million USD | 13.09% |
| 2005 FY | - USD | 167.36% |
| 2005 Q4 | 11.57 Million USD | 14.59% |
| 2005 Q1 | 6.04 Million USD | 353.45% |
| 2005 Q3 | 10.1 Million USD | 47.7% |
| 2004 Q2 | 6.04 Million USD | -14.25% |
| 2004 Q3 | -1.18 Million USD | -119.58% |
| 2004 Q1 | 7.04 Million USD | -56.99% |
| 2004 FY | - USD | -67.96% |
| 2004 Q4 | 1.33 Million USD | 212.76% |
| 2003 Q1 | 12.82 Million USD | 4.03% |
| 2003 FY | - USD | 19.22% |
| 2003 Q4 | 12.65 Million USD | 123.24% |
| 2003 Q2 | 7.83 Million USD | -43.03% |
| 2003 Q3 | 8.16 Million USD | 19.45% |
| 2002 Q2 | 9.2 Million USD | 17.89% |
| 2002 FY | - USD | 34.54% |
| 2002 Q4 | 10.72 Million USD | 45.16% |
| 2002 Q3 | 7.48 Million USD | -19.22% |
| 2002 Q1 | 7.87 Million USD | -7.63% |
| 2001 Q3 | 5.92 Million USD | -13.01% |
| 2001 Q2 | 6.78 Million USD | 18.96% |
| 2001 Q4 | 8.48 Million USD | 48.46% |
| 2001 Q1 | 5.96 Million USD | -9.69% |
| 2001 FY | - USD | 31.49% |
| 2000 Q2 | 5.51 Million USD | 3.17% |
| 2000 Q4 | 6.42 Million USD | 72.0% |
| 2000 FY | - USD | 20.36% |
| 2000 Q1 | 5.35 Million USD | -11.56% |
| 2000 Q3 | 3.93 Million USD | -32.18% |
| 1999 Q4 | 5.9 Million USD | 61.76% |
| 1999 Q2 | 4 Million USD | 9.09% |
| 1999 FY | - USD | 44.55% |
| 1999 Q3 | 3.7 Million USD | -5.56% |
| 1999 Q1 | 3.7 Million USD | 13.79% |
| 1998 Q3 | 3.2 Million USD | 7.69% |
| 1998 Q1 | 2.9 Million USD | 8.33% |
| 1998 FY | - USD | 27.91% |
| 1998 Q4 | 3.3 Million USD | 3.57% |
| 1998 Q2 | 2.9 Million USD | 0.0% |
| 1997 Q3 | 2.6 Million USD | 21.05% |
| 1997 Q2 | 2.2 Million USD | -13.64% |
| 1997 Q1 | 2.5 Million USD | 100.0% |
| 1997 FY | - USD | 28.36% |
| 1997 Q4 | 2.7 Million USD | 4.35% |
| 1996 Q2 | 2.1 Million USD | -21.74% |
| 1996 FY | - USD | 3.08% |
| 1996 Q3 | 1.7 Million USD | -22.22% |
| 1996 Q4 | 1.4 Million USD | -21.43% |
| 1996 Q1 | 2.6 Million USD | 21.05% |
| 1995 Q3 | 1.6 Million USD | -31.58% |
| 1995 Q4 | 2.2 Million USD | 46.15% |
| 1995 Q2 | 2 Million USD | 26.67% |
| 1995 FY | - USD | 51.16% |
| 1995 Q1 | 1.6 Million USD | 66.67% |
| 1994 FY | - USD | 2.38% |
| 1994 Q1 | 1.9 Million USD | -5.26% |
| 1994 Q2 | 1.4 Million USD | -33.33% |
| 1994 Q3 | 500 Thousand USD | -66.67% |
| 1994 Q4 | 1.1 Million USD | 125.0% |
| 1993 FY | - USD | -10.64% |
| 1993 Q4 | 2 Million USD | 280.0% |
| 1993 Q3 | 600 Thousand USD | 0.0% |
| 1993 Q2 | 700 Thousand USD | -61.54% |
| 1993 Q1 | 1.4 Million USD | 8.33% |
| 1992 Q1 | 1.4 Million USD | 182.35% |
| 1992 Q2 | 1 Million USD | -28.57% |
| 1992 Q3 | 1.1 Million USD | 10.0% |
| 1992 Q4 | 1.2 Million USD | 9.09% |
| 1992 FY | - USD | -31.88% |
| 1991 Q1 | 1.9 Million USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | 1.9 Million USD | 0.0% |
| 1991 Q3 | 1.9 Million USD | 0.0% |
| 1991 Q4 | -1.7 Million USD | -189.47% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 774.294% |
| AngioDynamics, Inc. | -14.29 Million USD | 2252.911% |
| AtriCure, Inc. | -8.1 Million USD | 3894.475% |
| Avinger, Inc. | -16.34 Million USD | 1982.381% |
| Azenta, Inc. | 55.15 Million USD | -457.912% |
| BioLife Solutions, Inc. | -45.23 Million USD | 780.167% |
| The Cooper Companies, Inc. | 882.8 Million USD | 65.146% |
| Daxor Corporation | 329.74 Thousand USD | -93214.126% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 2431.368% |
| Femasys Inc. | -13.16 Million USD | 2436.429% |
| GlucoTrack, Inc. | -7.09 Million USD | 4439.219% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -3141.273% |
| Hologic, Inc. | 1.29 Billion USD | 76.262% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 87.148% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 3373.484% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -528.075% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 4779.661% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 4779.661% |
| Masimo Corporation | 236.7 Million USD | -29.993% |
| Microbot Medical Inc. | -10.63 Million USD | 2993.493% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -1851.067% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -32.946% |
| Nephros, Inc. | -1.37 Million USD | 22412.835% |
| NovoCure Limited | -175.86 Million USD | 274.96% |
| NEXGEL, Inc. | -2.73 Million USD | 11370.842% |
| NEXGEL, Inc. | -2.73 Million USD | 11370.842% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 455.732% |
| OraSure Technologies, Inc. | 76.15 Million USD | -304.021% |
| Pro-Dex, Inc. | 8.33 Million USD | -3592.476% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 826.259% |
| Predictive Oncology Inc. | -13.18 Million USD | 2434.196% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 12349.204% |
| QuidelOrtho Corporation | 545.6 Million USD | 43.604% |
| Repligen Corporation | 124.29 Million USD | -147.557% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 106532.789% |
| STAAR Surgical Company | 33.22 Million USD | -826.203% |
| Sharps Technology, Inc. | -8.98 Million USD | 3526.287% |
| Utah Medical Products, Inc. | 24.8 Million USD | -1140.452% |
| DENTSPLY SIRONA Inc. | 232 Million USD | -32.627% |
| Jin Medical International Ltd. | 3.44 Million USD | -8837.098% |